Monitor for actual Form 4 filings confirming the sale; if executed, it would add to the recent insider selling trend (30d: $61K sells vs $11K buys). The small size limits downside pressure, but the CEO's intent to sell at current levels is a modest negative signal for a stock with weak historical insider accumulation.
Price Chart
Executive Summary
CEO Darren Sherman filed a Form 144 notice to sell 15,000 shares of Orchestra BioMed (OBIO) with an estimated aggregate market value of $75,300. The shares were acquired via restricted stock vesting on 11/25/2024 as compensation. This is a relatively small sale relative to the company's $303M market cap, but the CEO's intent to sell at current levels is a modest negative signal, especially given the company's weak historical insider activity pattern (only $11K in buys vs $61K in sells over the past 30 days). The filing is routine in size but notable due to the insider's position and the lack of offsetting bullish catalysts in the filing documents.
Key Facts
- CEO Darren Sherman filed Form 144 to sell 15,000 shares of OBIO common stock.
- Estimated aggregate market value of the proposed sale is $75,300.
- Shares were acquired via restricted stock vesting on 11/25/2024 as compensation.
- The sale is intended to be executed through Fidelity Brokerage Services LLC on the Nasdaq exchange.
- The filing date is 09/01/2026, with the notice covering intent to sell shares that were previously acquired through vesting.
Financial Impact
CEO proposes to sell $75,300 worth of OBIO common stock, representing a small fraction of the $303M market cap.
Risk Factors
- CEO selling may signal lack of confidence in near-term prospects.
- Form 144 is only an intent to sell; the sale may not be executed.
- Historical insider activity shows net selling over the past 30 days.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (OBIO) — Batch item 1 | 0001959173-26-006578 |
| Document: 0001959173-26-006578-index.html | 0001959173-26-006578 |
| Document: 0001959173-26-006578.txt | 0001959173-26-006578 |
| 144 Filing (OBIO) — Batch item 4 | 0001959173-26-006578 |
| Document: 0001959173-26-006578-index.html | 0001959173-26-006578 |
| Document: 0001959173-26-006578.txt | 0001959173-26-006578 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 144 | $6.35 $5.73 | ▼ −9.76% | ▼ −11.06% | $5.55 (−12.60%) |
Oct 1, 2026 26d ago | 8-K | $6.35 $5.73 | ▼ −9.76% | ▼ −11.06% | $5.55 (−12.60%) |
Sep 22, 2026 4w ago | Institutional Cluster | $6.22 $6.08 | ▼ −2.25% | ▼ −1.06% | $5.55 (−10.77%) |
Sep 8, 2026 7w ago | Insider Cluster | $5.43 $6.04 | ▲ +11.23% | ▲ +12.35% | $5.55 (+2.21%) |
Sep 1, 2026 8w ago | 144 | $4.90 $5.45 | ▼ −11.22% | ▼ −11.14% | $5.55 (−13.27%) |
Jul 1, 2026 16w ago | 144 | $4.30 $3.96 | ▼ −7.91% | ▼ −8.17% | $5.55 (+29.07%) |
Jun 2, 2026 20w ago | Insider Cluster | $3.86 $4.02 | ▲ +4.15% | ▲ +7.96% | $5.55 (+43.78%) |
May 19, 2026 23w ago | Insider Cluster | $4.00 $4.06 | ▲ +1.50% | ▼ −0.75% | $5.55 (+38.75%) |
Apr 29, 2026 25w ago | DEFA14A | $3.99 $3.93 | ▼ −1.50% | ▼ −3.23% | $5.55 (+39.10%) |
Apr 23, 2026 26w ago | Press Release | $4.15 $3.80 | ▼ −8.43% | ▼ −9.91% | $5.55 (+33.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers